发明名称 ROLE OF IFNG METHYLATION IN INFLAMMATORY BOWEL DISEASE
摘要 <p>A method of diagnosing susceptibility to inflammatory bowel disease (IBD) in an individual by obtaining a sample from the individual, assaying the sample to determine the presence or absence of one or more risk genetic variants and/or an increase in IFNG DNA methylation relative to a normal subject is disclosed. Susceptibility to inflammatory bowel disease or ulcerative colitis is diagnosed based on the presence of one or more risk genetic variants and/or an increase in IFNG DNA methylation.</p>
申请公布号 WO2012135146(A3) 申请公布日期 2013.12.27
申请号 WO2012US30616 申请日期 2012.03.26
申请人 CEDARS-SINAI MEDICAL CENTER;GONSKY, REBECCA;DEEM, RICHARD;TARGAN, STEPHAN R. 发明人 GONSKY, REBECCA;DEEM, RICHARD;TARGAN, STEPHAN R.
分类号 C12Q1/68;C07H21/04;G01N33/50 主分类号 C12Q1/68
代理机构 代理人
主权项
地址